GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Huahai Pharmaceutical Co Ltd (SHSE:600521) » Definitions » EPS Growth Rate (Future 3Y To 5Y Estimate)

Zhejiang Huahai Pharmaceutical Co (SHSE:600521) EPS Growth Rate (Future 3Y To 5Y Estimate) : N/A (As of Jun. 05, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Zhejiang Huahai Pharmaceutical Co EPS Growth Rate (Future 3Y To 5Y Estimate)?

EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Zhejiang Huahai Pharmaceutical Co's EPS Growth Rate (Future 3Y To 5Y Estimate) is N/A.

Competitive Comparison of Zhejiang Huahai Pharmaceutical Co's EPS Growth Rate (Future 3Y To 5Y Estimate)

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Huahai Pharmaceutical Co's EPS Growth Rate (Future 3Y To 5Y Estimate), along with its competitors' market caps and EPS Growth Rate (Future 3Y To 5Y Estimate) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhejiang Huahai Pharmaceutical Co's EPS Growth Rate (Future 3Y To 5Y Estimate) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Huahai Pharmaceutical Co's EPS Growth Rate (Future 3Y To 5Y Estimate) distribution charts can be found below:

* The bar in red indicates where Zhejiang Huahai Pharmaceutical Co's EPS Growth Rate (Future 3Y To 5Y Estimate) falls into.


Zhejiang Huahai Pharmaceutical Co  (SHSE:600521) EPS Growth Rate (Future 3Y To 5Y Estimate) Explanation

EPS Growth Rate (Future 3Y To 5Y Estimate) s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Zhejiang Huahai Pharmaceutical Co EPS Growth Rate (Future 3Y To 5Y Estimate) Related Terms

Thank you for viewing the detailed overview of Zhejiang Huahai Pharmaceutical Co's EPS Growth Rate (Future 3Y To 5Y Estimate) provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Huahai Pharmaceutical Co Ltd (SHSE:600521) » Definitions » EPS Growth Rate (Future 3Y To 5Y Estimate)
Comparable Companies
SHSE:600518 SHSE:600329 SHSE:600380 SZSE:002262 SHSE:600062 SHSE:603707 SZSE:300142 SHSE:600535 SHSE:600129 SZSE:002773 XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
Economic Development Zone, Xunqiao Town, Linhai, Taizhou, Zhejiang, CHN, 317024
Website
http://www.huahaipharm.com
Zhejiang Huahai Pharmaceutical Co Ltd provides formulations, active pharmaceutical ingredients, and intermediates in China and internationally. The company also offers pril products, including captopril, enalapril, and lisinopril.
Executives
Chen Bao Hua Director
Shang Fei senior management
Du Jun Director
Su Yan Director
Chen Dun Yuan senior management
Li Hong Director
Guo Si Jia senior management
Li Min senior management
Xu Bo senior management
Wang Jie senior management
Chen Qi Mao senior management
Zhang Hong senior management
Zhang Mei senior management
Zhu Yong Hua Directors, senior managers
Wang Yi Hua senior management

Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Headlines

No Headlines